Clinical Trial Update: Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI [Phase 4]

View source ↗

Summary

Phase IV trial comparing Betaseron versus Copaxone in relapsing forms of multiple sclerosis using triple-dose gadolinium MRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaseron (Interferon beta-1b)
• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2021-11-16